2014
Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China
Lou J, Blevins M, Ruan Y, Vermund SH, Tang S, Webb GF, Shepherd BE, He X, Lu H, Shao Y, Qian HZ. Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China. PLOS ONE 2014, 9: e90985. PMID: 24626165, PMCID: PMC3953201, DOI: 10.1371/journal.pone.0090985.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyHIV epidemicCondom useHIV prevalenceART coverageCombination prevention strategiesHIV/AIDSHIV testingHIV incidenceCombination interventionsBeijing MSMPrevention strategiesPrevalence estimatesPrevalenceEpidemic expansionMenInterventionEpidemicIncidenceBasic reproduction numberPrevention scenariosCurrent coverageSexReproduction numberIntervention levels
2010
Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique
Audet CM, Burlison J, Moon TD, Sidat M, Vergara AE, Vermund SH. Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique. BMC Public Health 2010, 10: 15. PMID: 20529358, PMCID: PMC2891693, DOI: 10.1186/1472-698x-10-15.Peer-Reviewed Original ResearchHIV/AIDSHealth care infrastructureHIV incidenceHIV epidemicSevere health worker shortagesHuman immunodeficiency virus (HIV) epidemicAntenatal clinic sitesChronic disease servicesAIDS mortality ratesHealth system strengtheningHealth worker shortagesHealth care systemTerms HIVDrug adherenceImmunodeficiency syndromeMost HIVHeterosexual infectionHIV prevalenceDisease servicesClinic sitesEpidemiological aspectsGeneral populationMortality ratePrevalence estimatesHIVPrevalence and Predictors of Colposcopic-Histopathologically Confirmed Cervical Intraepithelial Neoplasia in HIV-Infected Women in India
Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, Kelkar RS, Jenkins CA, Shepherd BE, Sahay S, Risbud AR, Vermund SH, Mehendale SM. Prevalence and Predictors of Colposcopic-Histopathologically Confirmed Cervical Intraepithelial Neoplasia in HIV-Infected Women in India. PLOS ONE 2010, 5: e8634. PMID: 20072610, PMCID: PMC2798747, DOI: 10.1371/journal.pone.0008634.Peer-Reviewed Original ResearchConceptsCervical intraepithelial neoplasiaCervical high-risk HPV DNASeverity of CINHigh-risk HPV DNAAntiretroviral therapyHPV DNAIndependent predictorsIntraepithelial neoplasiaCervical cancerEvidence of CINPrevalence of CINPrevalence estimatesMultivariable ordinal logistic regression analysisMultivariable ordinal logistic regressionAdvanced neoplastic diseaseNon-pregnant HIVTrue disease burdenCervical precancerous lesionsLogistic regression analysisOrdinal logistic regression analysisClinical suspicionCIN1 lesionsMedian agePreventable cancersCervical cytology
2008
Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors
Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. International Journal Of Infectious Diseases 2008, 13: 9-19. PMID: 18835208, PMCID: PMC2651958, DOI: 10.1016/j.ijid.2008.06.019.Peer-Reviewed Original ResearchConceptsHepatitis C antibodyHepatitis CHepatitis BRisk factorsAntigen prevalenceHigh burdenC antibodyActive hepatitis BChronic hepatitis CBlood product transfusionHigh-risk subgroupsHigh-risk populationNational prevalence estimatesMode of transmissionWorld's highest burdenUnsafe bloodChronic hepatitisProduct transfusionLiver failurePediatric populationHigh prevalenceHepatocellular carcinomaNeedle usePrevalence estimatesHealthy adults
1989
ESTIMATING POPULATION PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN URBAN AREAS WITH HIGH RATES OF INTRAVENOUS DRUG USE: A MODEL OF THE BRONX IN 1988
DRUCKER E, VERMUND S. ESTIMATING POPULATION PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN URBAN AREAS WITH HIGH RATES OF INTRAVENOUS DRUG USE: A MODEL OF THE BRONX IN 1988. American Journal Of Epidemiology 1989, 130: 133-142. PMID: 2787104, DOI: 10.1093/oxfordjournals.aje.a115304.Peer-Reviewed Original ResearchConceptsIntravenous drug usersDrug usersAIDS casesIntravenous drug-using populationHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionIntravenous drug useHuman immunodeficiency virusAge group 25HIV prevalence estimatesAge 13 yearsDrug-using populationsHIV seroprevalenceImmunodeficiency syndromeAIDS patientsImmunodeficiency virusRisk factorsVirus infectionUse populationGroup 25Seroprevalence rangesPopulation prevalencePrevalence estimatesDrug useHigh rate